Dessaint JP - Search Results

1

Effect of glatiramer acetate (Copaxone) given orally in human patients: interleukin-10 production during a phase 1 trial.

de Seze J, Edan G, Labalette M, Dessaint JP, Vermersch P. de Seze J, et al. Among authors: dessaint jp. Ann Neurol. 2000 May;47(5):686. Ann Neurol. 2000. PMID: 10805349 Clinical Trial. No abstract available.

2

[Regulation of the production of IgE in man].

Dessaint JP, Labalette M. Dessaint JP, et al. Allerg Immunol (Paris). 1994 Sep;26(7):238-47. Allerg Immunol (Paris). 1994. PMID: 7527216 Review. French.

3

Ontogeny of the immune system with special reference to IgE.

Dessaint JP, Labalette M. Dessaint JP, et al. Pediatr Pulmonol Suppl. 1997;16:3-5. doi: 10.1002/ppul.1950230803. Pediatr Pulmonol Suppl. 1997. PMID: 9443172 Review. No abstract available.

4

[Immunoglobulins E. Role in allergy and atopy].

Labalette M, Dessaint JP. Labalette M, et al. Among authors: dessaint jp. Rev Prat. 1997 Oct 1;47(15):1733-7. Rev Prat. 1997. PMID: 9406523 French. No abstract available.

5

Immunomodulatory effect of pentoxifylline during human allograft rejection: involvement of tumor necrosis factor-alpha and adhesion molecules.

Noel C, Copin MC, Hazzan M, Labalette M, Susen S, Lelievre G, Dessaint JP. Noel C, et al. Among authors: dessaint jp. Transplantation. 2000 Mar 27;69(6):1102-7. doi: 10.1097/00007890-200003270-00014. Transplantation. 2000. PMID: 10762214 Clinical Trial.

6

Pentoxifylline prevents upregulation of monocyte tissue factor in renal transplant recipients undergoing post-graft complications.

Susen S, Hazzan M, Labalette M, Zawadzki C, Dessaint JP, Lelièvre G, Jude B, Noël C. Susen S, et al. Among authors: dessaint jp. Thromb Haemost. 2000 Nov;84(5):764-9. Thromb Haemost. 2000. PMID: 11127852 Clinical Trial.

7

Improvement in the outcome of rejection with pentoxifylline in renal transplantation: a randomized controlled trial.

Noel C, Hazzan M, Labalette M, Coppin MC, Jude B, Dessaint JP, Lelievre G. Noel C, et al. Among authors: dessaint jp. Transplantation. 1998 Feb 15;65(3):385-9. doi: 10.1097/00007890-199802150-00015. Transplantation. 1998. PMID: 9484756 Clinical Trial.

8

Peripheral human CD8(+)CD28(+)T lymphocytes give rise to CD28(-)progeny, but IL-4 prevents loss of CD28 expression.

Labalette M, Leteurtre E, Thumerelle C, Grutzmacher C, Tourvieille B, Dessaint JP. Labalette M, et al. Among authors: dessaint jp. Int Immunol. 1999 Aug;11(8):1327-36. doi: 10.1093/intimm/11.8.1327. Int Immunol. 1999. PMID: 10421790

9

CD28 expression is increased in venom allergic patients but is not modified by specific immunotherapy.

Tsicopoulos A, Labalette M, Akoum H, Duez C, Wallaert B, Dessaint JP, Tonnel AB. Tsicopoulos A, et al. Among authors: dessaint jp. Clin Exp Allergy. 1996 Oct;26(10):1119-24. Clin Exp Allergy. 1996. PMID: 8911696

10

Recall response to cytomegalovirus in allograft recipients: mobilization of CD57+, CD28+ cells before expansion of CD57+, CD28- cells within the CD8+ T lymphocyte compartment.

Hazzan M, Labalette M, Noel C, Lelievre G, Dessaint JP. Hazzan M, et al. Among authors: dessaint jp. Transplantation. 1997 Mar 15;63(5):693-8. doi: 10.1097/00007890-199703150-00014. Transplantation. 1997. PMID: 9075840

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters